Key Features
Enhance your research with our curated data sets and powerful platform features. Pluto Bio makes it simple to find and use the data you need.
Learn MoreHypoxia inducible factor-1 (HIF-1) is a critical transcription factor for the hypoxic response, angiogenesis, normal hematopoietic stem cell regulation, and cancer development. Importantly, HIF-1 is also a key regulator for immune cell activation. In order to determine whether HIF-1 is sufficient for developing MDS phenotypes, we generated blood specific inducible HIF-1 transgenic mice. Using Vav1-Cre/Rosa26-loxP-Stop-loxP (LSL) rtTA driver, stable HIF-1 can be induced in a doxycycline administration dependent manner. After induction, HIF-1-induced mice developed thrombocytopenia, leukocytopenia, macrocytic anemia, and multi-lineage dysplasia. We also found activation of both innate and adaptive immunity in HIF-1- induced mice compared to those from control mice. Taken together, these data suggest that HIF-1 is sufficient to trigger a variety of key MDS features SOURCE: Yoshihiro HayashiLaboratory of Oncology Tokyo University of Pharmacy and Life Sciences
View on GEOView in PlutoEnhance your research with our curated data sets and powerful platform features. Pluto Bio makes it simple to find and use the data you need.
Learn MoreUse Pluto's intuitive interface to analyze and visualize data for this experiment. Pluto's platform is equipped with an API & SDKs, making it easy to integrate into your internal bioinformatics processes.
Read about post-pipeline analysisView quality control data and experiment metadata for this experiment.
Request imports from GEO or TCGA directly within Pluto Bio.
Chat with our Scientific Insights team